20 LATEST RESOURCES (23 INDEXED)
Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway · July 2022
Articles
Drugs-Real World Outcomes
Treatment Patterns during Major Depressive Episodes among Patients with Major Depressive Disorder: A Retrospective Database Analysis · June 2022
Articles
Drugs-Real World Outcomes
Impact of Medication Adherence on the Association Between Oral Anticoagulant Use and Risk of Dementia: A Retrospective Cohort Study using the Japanese Claims Database · June 2022
Articles
Drugs-Real World Outcomes
Polypharmacy in Australian Veterans with Post-Traumatic Stress Disorder Upon Admission to a Mental Health Facility: A Retrospective Chart Review · May 2022
Articles
Drugs-Real World Outcomes
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) · July 2021
Articles
Drugs-Real World Outcomes
Potentially Inappropriate Medication Use in Older Adults with Alzheimer’s Disease and Related Dementias Living in the Community: A Cross-Sectional Analysis · June 2021
Articles
Drugs-Real World Outcomes
Stroke Risk among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database · June 2021
Articles
Drugs-Real World Outcomes
Factors Associated with Hyponatremia in Patients Newly Prescribed Citalopram: A Retrospective Observational Study · May 2021
Articles
Drugs-Real World Outcomes
Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants · May 2021
Articles
Drugs-Real World Outcomes
Duloxetine Exposure during Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study · May 2021
Articles
Drugs-Real World Outcomes
Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-Occurring Substance Use Disorders: A Multicentre, Observational Study · February 2020
Articles
Drugs-Real World Outcomes
Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate · November 2019
Articles
Drugs-Real World Outcomes
Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study · March 2019
Articles
Drugs-Real World Outcomes
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics · January 2018
Articles
Drugs-Real World Outcomes
Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling? · January 2018
Articles
Drugs-Real World Outcomes
The Risk of Hip Fracture Due to Mirtazapine Exposure When Switching Antidepressants or Using Other Antidepressants as Add-On Therapy · September 2017
Articles
NCBI>Drugs-Real World Outcomes
Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case-Control Study in Australia · May 2017
Articles
NCBI>Drugs-Real World Outcomes
Prescription Drug Use and Polypharmacy among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis · November 2016
Articles
Drugs-Real World Outcomes
Differences in Benzodiazepine Receptor Agonist Use in Rural and Urban Older Adults · June 2016
Articles
NCBI>Drugs-Real World Outcomes
Haloperidol Use among Elderly Patients Undergoing Surgery: A Retrospective 1-Year Study in a Hospital Population · March 2016
Articles
Drugs-Real World Outcomes